Subscribe To
CYAD / Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call
CYAD News
By GlobeNewsWire
March 17, 2023
Celyad Oncology to announce full year 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company more_horizontal
By Seeking Alpha
August 5, 2022
Celyad Oncology SA's (CYAD) CEO Michel Lussier on Q2 2022 Results - Earnings Call Transcript
Celyad Oncology SA (NASDAQ:CYAD ) Q2 2022 Earnings Conference Call August 5, 2022 8:00 AM ET Company Participants Sara Zelkovic - Director, Communicat more_horizontal
By GlobeNewsWire
July 28, 2022
Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium, July 28, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo more_horizontal
By Business Wire
July 28, 2022
Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) more_horizontal
By Seeking Alpha
July 19, 2022
Celyad: Probably Still Top-Notch In Oncology
Celyad is a seemingly neglected immuno-oncology-focused nano-cap, liked by analysts and experts abound, but somehow overlooked by the market. Four mon more_horizontal
By GlobeNewsWire
May 17, 2022
Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biote more_horizontal
By Seeking Alpha
March 25, 2022
Celyad Oncology SA (CYAD) CEO Filippo Petti on Q4 2021 Results - Earnings Call Transcript
Celyad Oncology SA (CYAD) CEO Filippo Petti on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Business Wire
March 17, 2022
Celyad Oncology to Announce Full Year 2021 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) more_horizontal